Department of Health and Human Services · UII 009-000388078

FDA CDER OTS Regulatory Science & Research

CIO Rating
FY2025 Funding (PY)
$7.8M
Recompete
Low
Active Contracts
8

Recompete Signal

Recompete Probability: Low

No near-term contract end with BY funding and no sustained CIO trouble.

CIO Rating Trend

Awaiting CIO evaluation data.

IT Dashboard publishes CIO ratings quarterly. This investment has not yet been rated or its data has not synced.

Funding Trend

$4.7M
FY2020
PY
$4.7M
FY2021
PY
$7.1M
FY2022
PY
$7.6M
FY2023
PY
$7.4M
FY2024
PY
$7.8M
FY2025
PY
Internal funding (agency's own budget)Contribution (working-capital / inter-agency)CY = current year · BY = budget year (projected) · PY = prior year

Cost Pool Breakdown

Where the FY2025 spend went, broken down by category.

External Labor
$2.1M
Software
$177K
Hardware
$135K
Internal Labor
$0

Active Contracts

PrimePIIDAmountPoP StartPoP End
75F40122F19005
75F40123P00422
75F40123F80277
75F40123F80298
75F40124F80298
75F40124F19019
75F40124P00441
75F40124F19007

Get the AI Pursuit Report for "FDA CDER OTS Regulatory Science & Research"

Strategic interpretation, personalized fit score (NAICS + certs + past performance), incumbent analysis, and win-themes recommendations. ~6-8 page PDF, generated in 30 seconds.

$49 per report

Or included in Pro ($799/mo, 25 reports/month) and Enterprise (unlimited)